Biliary tract cancers (BTCs) refer to a group of rare and aggressive malignancies affecting the biliary system. BTCs include cancer of the gallbladder, bile ducts, and ampulla of Vater. Early diagnosis of BTCs is challenging due to non-specific symptoms manifested at advanced stages of the disease. The available treatment landscape for BTCs relies on surgical resection along with adjuvant chemotherapy and radiation therapy. However, prognosis remains poor with 5-year survival rates of less than 20%.
The biliary tract cancers (BTCs) market is estimated to be valued at USD 0.822 billion in 2024 and is expected to reach USD 1.196 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.
Key Takeaways
Key players operating in the BTCs market are F. Hoffmann-La Roche AG, Pfizer, Inc., Bristol-Myers Squibb, Sanofi, and Merck & Co., Inc.
Growing incidence of biliary tract cancers, especially in developing economies of Asia Pacific is generating high demand for diagnosis and treatment. According to estimates, over 160,000 new cases of BTCs are diagnosed globally each year.
The Biliary Tract Cancers (BTCs) Market advancements in scientific understanding of molecular drivers involved in BTC pathogenesis and development of targeted therapies like immune checkpoint inhibitors and EGFR inhibitors hold potential to improve patient outcomes in future. Ongoing clinical trials are evaluating the efficacy and safety of molecularly targeted agents for BTCs.
Market Trends
Increased focus on early diagnosis: Growing research focus on identification of potential biomarkers for early detection of BTCs before symptoms appear is a major trend. Liquid biopsies for detection of cell-free DNA are being explored.
Targeted therapeutic approaches: Development of targeted therapies tailored to specific molecular profiles of individual BTC tumors is a key trend. Advances in genomic profiling are helping to identify optimal targeted agents.
Market Opportunities
Asia Pacific region presents high growth opportunity: Large patient population and improving access to healthcare facilities in developing Asian countries are encouraging pharmaceutical companies to tap into the region’s market potential.
Combination therapy approaches: Combining immunotherapy with targeted therapies holds promise to achieve improved and durable responses. Clinical trials evaluating combinations are ongoing.
Impact of COVID-19 on Biliary Tract Cancers (BTCs) Market Growth
The COVID-19 pandemic has significantly impacted the growth of the Biliary Tract Cancers (BTCs) market. During the initial outbreak, most of the hospitals and clinics shifted their focus towards treating COVID-19 patients which led to postponement of cancer screening procedures and surgeries. This resulted in delay in BTCs diagnosis and treatment. Furthermore, people were hesitant in visiting hospitals for their regular checkups due to fear of infection which lowered the number of new cases detected.
However, with easing of lockdowns and normalization of healthcare services, the market is recovering gradually. The healthcare facilities have now implemented strict safety protocols like social distancing, use of PPE kits and sanitization to prevent spread of virus. They are encouraging people to seek immediate medical assistance for any cancer symptoms. The pharmaceutical companies are striving to ensure uninterrupted supply of drugs used in BTCs treatment. Telehealth and teleconsultations are also being utilized to provide medical guidance to patients from remote locations.
Regions with high market concentration
North America has the highest BTCs market value currently due to developed healthcare infrastructure and widespread medical insurance coverage supporting cancer care expenses. However, Asia Pacific region is projected to be the fastest growing market owing to rising healthcare expenditure, increasing cancer incidence rates and growing medical tourism industry in countries like India, China and Japan.
Fastest growing region for the market
Europe also captures sizable BTCs market share led by Germany, France and United Kingdom. Meanwhile, Latin America and Middle East & Africa offer lucrative opportunities for players to tap into developing healthcare sectors and large patient populations.
Get More Insights On- Biliary Tract Cancers (BTCs) Market
Get This Report in Japanese Language: 胆道がん（BTC）市場
Get This Report in Korean Language: 담관암(BTC) 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek